TNDMHIGH SIGNALFINANCIAL10-K

TNDM experienced severe financial deterioration with operating cash flow swinging from positive $24.2M to negative $9.7M and net losses more than doubling to $204.7M.

The company's financial performance has deteriorated dramatically across all key metrics, indicating serious operational challenges that have significantly impacted profitability and cash generation. The removal of debt-related risk factors while financial performance worsens suggests potential debt restructuring or refinancing that wasn't fully disclosed, creating additional uncertainty for investors.

Comparing 2026-02-19 vs 2025-02-26View on EDGAR →
FINANCIAL ANALYSIS

TNDM's financial position deteriorated significantly with net losses more than doubling to $204.7M and operating cash flow turning negative from a positive $24.2M in the prior year. R&D expenses surged 44.8% to $92.1M while SG&A costs increased 14.2% to $445.0M, contributing to the massive operating loss expansion. Despite growing cash reserves 30.9% to $90.6M, stockholders' equity plummeted 41% to $155.2M, and the 44.4% increase in accounts receivable suggests potential collection issues, painting an overall picture of a company in serious financial distress.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-140.1%
$24.2M-$9.7M

Operating cash flow fell 140.1% — earnings quality concerns; investigate working capital changes and non-cash items.

Net Income
P&L
-113.2%
-$96.0M-$204.7M

Net income declined 113.2% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-88.9%
-$99.1M-$187.3M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

R&D Expense
P&L
+44.8%
$63.6M$92.1M

R&D investment increased 44.8% — signals commitment to future product development, though near-term margin impact.

Accounts Receivable
Balance Sheet
+44.4%
$114.6M$165.5M

Receivables surged 44.4% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Stockholders Equity
Balance Sheet
-41%
$263.1M$155.2M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Cash & Equivalents
Balance Sheet
+30.9%
$69.2M$90.6M

Cash position surged 30.9% — strong cash generation or capital raise providing significant financial cushion.

Current Assets
Balance Sheet
-14.7%
$724.5M$618.1M

Current assets declined 14.7% — monitor working capital adequacy and short-term liquidity.

SG&A Expense
P&L
+14.2%
$389.8M$445.0M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Inventory
Balance Sheet
-13.9%
$149.6M$128.8M

Inventory reduced 13.9% — lean inventory management or demand outpacing supply.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-26
ADDED
As of February 16, 2026, there were 68,325,927 shares of the registrant s common stock outstanding.
We are implementing a multi-channel managed care strategy in the United States that impacts the pricing model for our pumps and our supplies sold through the pharmacy channel.
If our pharmacy channel strategy fails to achieve its intended outcome, our growth, business, results of operations, and financial condition could be materially and adversely impacted.
Our ability to maintain and grow our sales depends in part on retaining a high percentage of our customer base.
Our sales and marketing efforts depend on independent distributors who are free to market products that compete with our products.
+7 more — sign up free →
REMOVED
As of February 21, 2025, there were 66,473,272 shares of the registrant s common stock outstanding.
2 Our ability to maintain and grow our revenue depends in part on retaining a high percentage of our customer base.
Our sales and marketing efforts in the United States are largely dependent on independent distributors who are free to market products that compete with our products.
Risks Related to Our International Operations Commercializing our products outside of the United States may result in a variety of risks associated with international operations that could materially adversely affect our business.
Risks Related to Our Indebtedness We have incurred a significant amount of indebtedness and the agreements governing such indebtedness subject us to required debt service payments, as well as financial and operational covenants, any of which may restrict our financial flexibility and affect our ability to operate our business.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →